- Home
- IOVA vs AMTB Comparison
IOVA vs AMTB Comparison
Compare IOVA & AMTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- AMTB
- Stock Information
- Founded
- IOVA 2007
- AMTB 1979
- Country
- IOVA United States
- AMTB United States
- Employees
- IOVA N/A
- AMTB N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- AMTB Major Banks
- Sector
- IOVA Health Care
- AMTB Finance
- Exchange
- IOVA Nasdaq
- AMTB Nasdaq
- Market Cap
- IOVA 975.1M
- AMTB 792.0M
- IPO Year
- IOVA N/A
- AMTB N/A
- Fundamental
- Price
- IOVA $2.31
- AMTB $18.36
- Analyst Decision
- IOVA Buy
- AMTB Buy
- Analyst Count
- IOVA 11
- AMTB 4
- Target Price
- IOVA $11.90
- AMTB $24.00
- AVG Volume (30 Days)
- IOVA 10.3M
- AMTB 200.7K
- Earning Date
- IOVA 11-06-2025
- AMTB 10-23-2025
- Dividend Yield
- IOVA N/A
- AMTB 2.00%
- EPS Growth
- IOVA N/A
- AMTB N/A
- EPS
- IOVA N/A
- AMTB 0.09
- Revenue
- IOVA $241,525,000.00
- AMTB $305,477,000.00
- Revenue This Year
- IOVA $68.14
- AMTB $62.62
- Revenue Next Year
- IOVA $56.64
- AMTB $6.74
- P/E Ratio
- IOVA N/A
- AMTB $199.01
- Revenue Growth
- IOVA 636.99
- AMTB N/A
- 52 Week Low
- IOVA $1.64
- AMTB $16.21
- 52 Week High
- IOVA $12.51
- AMTB $26.24
- Technical
- Relative Strength Index (RSI)
- IOVA 53.84
- AMTB 40.97
- Support Level
- IOVA $2.13
- AMTB $17.55
- Resistance Level
- IOVA $2.31
- AMTB $19.16
- Average True Range (ATR)
- IOVA 0.13
- AMTB 0.60
- MACD
- IOVA 0.02
- AMTB -0.07
- Stochastic Oscillator
- IOVA 72.97
- AMTB 44.48
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About AMTB Amerant Bancorp Inc.
Amerant Bancorp Inc is a bank holding company. Through its bank, it provides individuals and businesses deposit, credit, investment, wealth management, and fiduciary services, both in the United States and to select international customers. The bank also provides banking services through traditional channels, such as banking centers and ATMs, as well as via secure websites, mobile devices and telephones.